An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study of CDX-585 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
- Status
- RECRUITING
- Phase
- N/A
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2